AzTrials
AzTrials

Athletic PerformanceNCT05936398

Influence of Respiratory Muscle Training on Objective and Subjective Training Load Measures in Triathletes

A study testing Respiratory Muscle Training - VIH and Respiratory Muscle Training - ITPL in people with Athletic Performance, run by Institute of Sport - National Research Institute, Poland at 1 site in Poland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Two groups of healthy, highly trained triathletes trained respiratory muscles with one of the two methods: voluntary isocapnic hyperpnoea (VIH) or inspiratory pressure threshold loading (IPTL). Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Athletic Performance
What is being tested?
Respiratory Muscle Training - VIH and Respiratory Muscle Training - ITPL
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 sitePoland
Study dates
1 Mar 2023to 30 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • valid medical certificate to compete sports professionally,
  • lack of ongoing medication intake,
  • lack of any medical condition,
  • lack of previous experience with RMT,
  • lack of previous experience with RMT,
  • performance caliber corresponding to at HighlyTrained/Elite (Participant Classification Framework, McKay 2022),
  • at least 6 years of triathlon training,
  • average training volume over 12 hours per week during last 6 weeks.

Who cannot join

  • any ongoing medication intake or medical condition.

Trial locations and contacts

1 site in 1 country.

Poland1 site
  • Institute of Sport - National Research Institute

    Warsaw, 01-982

Other trials in Poland

About this study

Two groups of healthy, highly trained triathletes trained respiratory muscles with one of the two methods: voluntary isocapnic hyperpnoea (VIH) or inspiratory pressure threshold loading (IPTL). The main purpose of this study was to accurately and thoroughly assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods.

Informed written consent was obtained from the all study participants. All procedures were carried out in accordance with the Declaration of Helsinki.

Read the detailed description

The study was conducted as a randomized controlled trial with two parallel groups. Whereas participants and data collectors were aware of the allocated training method, the data analysts and laboratory technicians performing biochemistry assays were kept blinded to the allocation. The participants were assigned at random to either VIH or IPTL training group to perform RMT with progressive overload for 6 weeks.

Three training sessions (week 1, 4, 6) were monitor to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods.

Blood samples used for acid-base balance (pH), partial pressure of oxygen (pO2), partial pressure for carbon dioxide (pCO2), partial pressure for bicarbonate ion (HCO3-), and blood lactate (bLa) were collected immediately after cessation of the exercise and MPQ was presented 1' after cessation of the exercise. Blood samples for cortisol (C) and testosterone (T) were collected 5' after cessation of the exercise. The second S-Index Test was performed between minute 5 and minute 7 after cessation of the exercise. RPE was assessed 10' after cessation of the exercise. The participants again answered MPQ after 24h and 48h after the monitored RMT sessions.

Informed written consent was obtained from the all study participants. All procedures were carried out in accordance with the Declaration of Helsinki.

Being tested
Respiratory Muscle Training - VIH, Respiratory Muscle Training - ITPL

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Respiratory Muscle Training - VIHBehavioural

    The VIH group will train every second day with gradual progression based on session length and breathing frequency. Participants will begin with 3 minutes of exercise with a frequency of 20 breaths·min-1 during the first session and add no more than 1 minute or 2 breaths·min-1 with each consecutive session.

  • Respiratory Muscle Training - ITPLBehavioural

    The IPTL group will train 5 days a week, twice a day, with at least 6 hours break between sessions. The session will consist of 30 dynamic inspiratory maneuvers with progressive overload based on gradually increased resistance. The VIH group will train every second day with gradual progression based on session length and breathing frequency. Participants will begin with 3 minutes of exercise with a frequency of 20 breaths·min-1 during the first session and add no more than 1 minute or 2 breaths·min-1 with each consecutive session.

Study groups in NCT05936398
Study groupRoleWhat they receive
Voluntary Isocapnic Hyperpnoea (VIH)Active comparatorGroup performing respiratory muscle training with Voluntary Isocapnic Hyperpnoea (VIH) method.
Receives: Behavioral: Respiratory Muscle Training - VIH
Inspiratory Pressure Threshold Loading (IPTL)Active comparatorGroup performing respiratory muscle training with Inspiratory Pressure Threshold Loading (IPTL) method.
Receives: Behavioral: Respiratory Muscle Training - ITPL

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in measured blood indices to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods (pH)

    Differences in pre- and post- RMT session in pH.

    Measured: Week 1, 4 and 6 after monitored RMT sessions.

  2. Changes in measured blood indices to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods (pO2).

    Differences in pre- and post- RMT session in pO2.

    Measured: Week 1, 4 and 6 after monitored RMT sessions.

  3. Changes in measured blood indices to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods (pCO2).

    Differences in pre- and post- RMT session in pCO2.

    Measured: Week 1, 4 and 6 after monitored RMT sessions.

  4. Changes in measured blood indices to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods (CHO3).

    Differences in pre- and post- RMT session in CHO3. CHO3.

    Measured: Week 1, 4 and 6 after monitored RMT sessions.

  5. Changes in measured blood indices to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods (lactate).

    Differences in pre- and post- RMT session in blood lactate levels.

    Measured: Week 1, 4 and 6 after monitored RMT sessions.

  6. Changes in measured blood indices to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods (testosterone).

    Differences in pre- and post- RMT session in testosterone.

    Measured: Week 1, 4 and 6 after monitored RMT sessions.

  7. Changes in measured blood indices to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods (cortisol).

    Differences in pre- and post- RMT session in cortisol.

    Measured: Week 1, 4 and 6 after monitored RMT sessions.

  8. Changes in cardiac indices to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods.

    Differences in HR indices between methods, increase of HR and decrease of HR after the cessation on the exercise.

    Measured: Week 1, 4 and 6 after monitored RMT sessions.

  9. Collecting subjective measures to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods (RPE)

    Collecting perceived exertion numbers (Rate of Perceived Exertion - RPE)

    Measured: Week 1, 4 and 6 after monitored RMT sessions.

  10. Collecting subjective measures to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods (MPQ).

    Collecting McGill Pain Questionnaire immediately post-session (MPQ scale).

    Measured: Week 1, 4 and 6 after monitored RMT sessions.

  11. Collecting local blood oxygenation during RMT to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods.

    Measuring SMO2 before, during and after RMT sessions to assess induced changes.

    Measured: Week 1, 4 and 6 after monitored RMT sessions.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jul 2023
  2. Study start1 Mar 2023
  3. Primary completion30 Apr 2023
  4. Study completion30 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05936398
Sponsor's protocol ID
TK02/2023
Status last verified
Jun 2023
First submitted
23 Jun 2023
Last updated
7 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Respiratory Muscle Training - VIH and Respiratory Muscle Training - ITPL in people with Athletic Performance, run by Institute of Sport - National Research Institute, Poland at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in measured blood indices to assess the potential extra load that RMT puts on athletes and determine if there are significant differences in RMT-induced load between the investigated training methods (pH) (time frame: Week 1, 4 and 6 after monitored RMT sessions.). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2023; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in